Showing 1 - 10 results of 10 for search 'Sayem Borhan', query time: 0.04s
Refine Results
-
1
-
2
Analysis and reporting of stratified cluster randomized trials—a systematic survey by Sayem Borhan, Alexandra Papaioannou, Jinhui Ma, Jonathan Adachi, Lehana Thabane
Published 2020-11-01
Article -
3
-
4
Decision support intervention (Plan Well Guide) for patients and their substitute decision-makers to improve engagement in advance care planning: protocol for a randomised trial by Michelle Howard, Daren K Heyland, Amy Tan, Carrie Bernard, Marissa Slaven, Sayem Borhan, Dawn Elston, Neha Arora
Published 2019-09-01
Article -
5
Persistent COVID-19 symptoms in community-living older adults from the Canadian Longitudinal Study on Aging (CLSA) by Lauren E. Griffith, Marla Beauchamp, Jacqueline McMillan, Sayem Borhan, Urun Erbas Oz, Christina Wolfson, Susan Kirkland, Nicole E. Basta, Mary Thompson, Parminder Raina, on behalf of the Canadian Longitudinal Study on Aging (CLSA) Team
Published 2023-03-01
Article -
6
The co-occurrence of multimorbidity and polypharmacy among middle-aged and older adults in Canada: A cross-sectional study using the Canadian Longitudinal Study on Aging (CLSA) and... by Kathryn Nicholson, Jennifer Salerno, Sayem Borhan, Benoit Cossette, Dale Guenter, Meredith Vanstone, John Queenan, Michelle Greiver, Michelle Howard, Amanda L Terry, Tyler Williamson, Lauren E Griffith, Martin Fortin, Saverio Stranges, Dee Mangin
Published 2025-01-01
Article -
7
Health TAPESTRY Ontario: protocol for a randomized controlled trial to test reproducibility and implementation by Dee Mangin, Larkin Lamarche, Doug Oliver, Sivan Bomze, Sayem Borhan, Tracy Browne, Tracey Carr, Julie Datta, Lisa Dolovich, Michelle Howard, Sarah Marentette-Brown, Cathy Risdon, Samina Talat, Jean-Eric Tarride, Lehana Thabane, Ruta Valaitis, David Price
Published 2020-08-01
Article -
8
Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy by Dee Mangin, Larkin Lamarche, Gina Agarwal, Abbas Ali, Alan Cassels, Kiska Colwill, Lisa Dolovich, Naomi Dore Brown, Barbara Farrell, Karla Freeman, Kristina Frizzle, Scott R. Garrison, James Gillett, Anne Holbrook, Jane Jurcic-Vrataric, James McCormack, Jenna Parascandalo, Julie Richardson, Cathy Risdon, Diana Sherifali, Henry Siu, Sayem Borhan, Jeffery A. Templeton, Lehana Thabane, Johanna Trimble
Published 2023-05-01
Article -
9
Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway by Dee Mangin MBChB, DPH, Larkin Lamarche PhD, Karla Freeman MSc, Abbas Ali MPH, Rebecca Clark MSc, Nikki Shah MD, Amen Awan BSc, Jessica Langevin MPH, Jenna Parascandalo MPH, Naomi Dore Brown PharmD, Jane Jurcic-Vrataric PharmD, Kiska Colwill BScPharm, Steven Dragos MSc, Sayem Borhan PhD, Cathy Risdon MD, DMan, Henry Siu MD, Barbara Farrell PhD, Johanna Trimble
Published 2023-05-01
Article -
10
Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial by Dee Mangin, Larkin Lamarche, Gina Agarwal, Hoan Linh Banh, Naomi Dore Brown, Alan Cassels, Kiska Colwill, Lisa Dolovich, Barbara Farrell, Scott Garrison, James Gillett, Lauren E. Griffith, Anne Holbrook, Jane Jurcic-Vrataric, James McCormack, Daria O’Reilly, Parminder Raina, Julie Richardson, Cathy Risdon, Mat Savelli, Diana Sherifali, Henry Siu, Jean-Éric Tarride, Johanna Trimble, Abbas Ali, Karla Freeman, Jessica Langevin, Jenna Parascandalo, Jeffrey A. Templeton, Steven Dragos, Sayem Borhan, Lehana Thabane
Published 2021-10-01
Article